Page 5«..4567..1020..»

Nanomedicine Market by Key Manufacturers, Regions, Risk Analysis, Industry Share, Driving Factors, Deployment Policy, Innovative Technology, Product…

Global Nanomedicine Market report provides you with detailed insights, industry knowledge, market forecasts and analytics. The report on the global Nanomedicine industry also clarifies economic risks and environmental compliance. Global Nanomedicine market report assists industry enthusiasts including investors and decision makers to make confident capital investments, develop strategies, optimize their business portfolio, innovate successfully and perform safely and sustainably.

Request Sample Copy of this Report @

Key Companies

The report offers detailed coverage of Nanomedicine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Nanomedicine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @

Key Product Type

Market by Application

Nanomedicine Market Segment by Regions

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania

Europe: Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland

North America: United States, Canada, Mexico

Middle East & Africa: GCC, North Africa, South Africa

South America: Brazil, Argentina, Columbia, Chile, Peru

The key points of the Nanomedicine Market report:

Get Complete Report in your Inbox within 24 hours @

Global Nanomedicine Market providing information such as company profiles, product picture, and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis are also carried out. The Global Nanomedicine market development trends and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

Key Points from Table of Content

1 Nanomedicine Industrial Chain Overview2 Global Nanomedicine Market Production & Consumption by Geography3 Nanomedicine Market Major Manufacturers Introduction4 Nanomedicine Market Competition Pattern5 Nanomedicine Product Type Segment6 Nanomedicine End-Use Segment7 Nanomedicine Market Forecast & Trend8 Nanomedicine Price & Channel9 Nanomedicine Market Drivers & Investment Environment10 Research Conclusion

* If you need anything more than these then let us know and we will prepare the report according to your requirement.

About Us

Prominent Market Research has an extensive coverage of diligence verticals of qualitative and quantitative reports across all the industries. In case your needs are not met by syndicated reports untaken by the foremost publishers, we can help you by proposing a customized research elucidation by liaising with different research interventions saving your valuable time and money. We have experienced and trained staff that helps you navigate different options and lets you choose preeminent research solution at most effective cost.

Contact Us

Michael, Sales Manager

Prominent Market Research

7309 Woodward Ave,

Apt 107, Woodridge, Illinois, USA, 60517

Phone: USA +1-630-361-6262

Email: [emailprotected]

Corporate Sales: [emailprotected]

See the original post:
Nanomedicine Market by Key Manufacturers, Regions, Risk Analysis, Industry Share, Driving Factors, Deployment Policy, Innovative Technology, Product...

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Musician Hacks Prosthetic Arm to Control Synthesizer and Play Music With His Thoughts – Interesting Engineering

This musician hacked his prosthetic arm so that he can play music with his thoughts.

Bertolt Meyer is a musician and an engineer at heart, who was born without a lower left arm. He has worn a prosthetic arm since he was just 3 months old, however, now he is wearing an I-Limb that looks like something out of a futuristic cyberpunk movie.

What he is wearing is a myoelectric prosthesis, which uses electrical signals from the muscles inside the residual limb to control movement.

As an electric musician himself, Meyer had the idea to swap out the prosthetic hand for a DIY controller for his modular synthesizers. This is nothing short of genius since now he can play music just by thinking about it. He's calling the design "SynLimb."

This allows him to plug his prosthesis directly into the synthesizer and control its parameters with the signals from his body that would normally control a hand.

The video shows the amazing process in action. While Meyer talks about this as an exciting little project for him, it truly does hold promise and potential for the future of transhumanism.

See the original post:
Musician Hacks Prosthetic Arm to Control Synthesizer and Play Music With His Thoughts - Interesting Engineering

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

United States’ Genomic Biomarker Industry, 2020: Market Overview & Insights, Lucrative Segments, Competitive Landscape, Key Player Profiles, and…

DUBLIN, Feb. 18, 2020 /PRNewswire/ -- The "US Genomic Biomarker Market 2019-2025" report has been added to's offering.

The US genomic biomarker market is estimated to grow significantly at a CAGR of around 15.6% during the forecast period.

Factors that are contributing significantly to the market growth include the presence of well-developed healthcare infrastructure, increasing healthcare R&D investments, high healthcare expenditure and others. Moreover, the market growth is attributed to the rising prevalence of cancer, CVDs, and chronic diseases. The rising number of cancer patients is considered to be one of the major factors that are driving the growth of the market in the US.

The US genomic biomarker market is segmented on the basis of application and end-user. On the basis of application, the market is segmented into oncology, cardiology, neurology, and others. There is a huge scope for the market in the oncology segment due to the increasing prevalence of cancer. A genomic biomarker can detect various types of diseases. However, most of the research institutes are majorly focused on oncology diagnosis and therapeutics. The genomic biomarker is widely used for the diagnosis of various types of cancer across the globe. On the basis of end-user, the market is segmented into hospitals and diagnostic.

The major players in the North American genomic biomarker market include Agilent Technologies, Inc., Qiagen N.V., Illumina, Inc., Myriad Genetics, Inc., Thermo Fischer Scientific, Inc., Genomic Health Inc., Bio-Rad Laboratories Inc., and Hologic, Inc. These players have been focusing on new product developments as well as upgrading their product portfolios to stay competitive in the market.

Product launch, geographic expansion, and mergers and acquisitions are some of the key strategies adopted by the market players in the past few years. For instance, In July 2017, Agilent Technologies, Inc. introduced Agilent Sure select which is advanced high sensitivity Next-Generation Sequencing (NGS) target enrichment solution for research, sequence DNA from formalin-fixed paraffin-embedded samples.

This report covers:

Key Topics Covered

1. Report Summary1.1. Research Methods and Tools1.2. Market Breakdown1.2.1. By Segments

2. Market Overview and Insights2.1. Scope of the Report2.2. Analyst Insight & Current Market Trends2.2.1. Key Findings2.2.2. Recommendations2.2.3. Conclusion2.3. Rules & Regulations

3. Competitive Landscape3.1. Company Share Analysis 3.2. Key Strategy Analysis3.3. Key Company Analysis3.3.1. Overview3.3.2. Financial Analysis3.3.3. SWOT Analysis3.3.4. Recent Developments

4. Market Determinants 4.1. Motivators4.2. Restraints4.3. Opportunities

5. Market Segmentation5.1. US Genomic Biomarker Market by Application5.1.1. Oncology5.1.2. Cardiology5.1.3. Neurology5.1.4. Others5.2. US Genomic Biomarker Market by End-User5.2.1. Hospitals5.2.2. Diagnostic & Research Laboratories

6. Company Profiles6.1. Abbott Laboratories Inc.6.2. Agilent Technologies, Inc.6.3. Banyan Biomarkers, Inc.6.4. Beckman Coulter Inc.6.5. Becton, Dickson and Co.6.6. Bio-Rad Laboratories, Inc.6.7. Celgene Corp.6.8. Cofactor Genomics, Inc.6.9. Empire Genomics, LLC6.10. Enzo Life Sciences, Inc.6.11. Foundation Medicine, Inc.6.12. Genomic Health, Inc.6.13. Hologic, Inc.6.14. Human Longevity, Inc.6.15. Illumina, Inc.6.16. Insight Genetics, Inc.6.17. Inova Diagnostics, Inc.6.18. Luminex Corp.6.19. Myriad Genetics, Inc.6.20. NanoString Technologies, Inc.6.21. NeoGenomics, Inc.6.22. OriGene Technologies, Inc.6.23. Pacific Biomarker Inc.6.24. Pfizer, Inc.6.25. Pliant Therapeutics, Inc.6.26. Quest Diagnostics Inc.6.27. Response Biomedical Corp.6.28. Signosis Inc.6.29. Thermo Fisher Scientific Inc.6.30. Verge Genomics Inc.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

See more here:
United States' Genomic Biomarker Industry, 2020: Market Overview & Insights, Lucrative Segments, Competitive Landscape, Key Player Profiles, and...

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Precision Medicine Software Market to Register the Highest Growth Rate by Applications, and Future F –

Meticulous Research leading global market research company is researching on precision medicine software market titled Precision Medicine Software Market by Delivery Mode (On-Premise, Cloud-Based), Application (Oncology, Pharmacogenomics, rare diseases), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies), and Geography-Global Forecast to 2025.

Nowadays, rising advances in big data technology applications for accurate disease detection is creating a positive impact on the precision medicine software market over the forecast period. Moreover, the introduction of various software with an improved clinical workflow will likely increase the ability to store a large amount of genetic data to ensure rapid patient recovery. The factors such as growing acceptance of big data analysis and sequencing of gene therapy are expected to drive the growth of the precision software market during the forecast period.

Download Free Sample Copy Of The Report::

Key questions answered in the report-

What are the major drivers, restraints, challenges, and opportunities in the precision medicine software market?

Who are the major players in various countries and what share of the market do they hold?

What are the geographical trends and high growth regions/ countries?

Who are the top competitors in this market and what strategies do they employ to gain shares?

What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?

What strategies should new companies looking to enter in this market use to compete effectively?

Who are the major players in the global precision medicine software market and what share of the market do they hold?

What are the local emerging players in the global precision medicine software market and how do they compete with the global players?

Have Any Query? Ask Our Expert

(In case of any queries or customization requirements please connect with our Experts by Clicking Here who will ensure that your requirements are met.)

On-Premise Delivery Mode Dominated the Precision Medicine Software Market in 2018

On the basis of delivery mode, the precision medicine software market is segmented into on-premise and cloud-based delivery model. On-premises commanded the largest share of precision medicine software market in 2018. The large market share of this segment is primarily attributed to the wide range of advantages regarding the use of on-premise delivery model. However, cloud-based delivery mode segment is expected to grow at the highest rate during the forecast period due to its rising adoption in healthcare organizations for sharing and integrating information from different locations.

Health Providers to Register the Highest Growth, by End User

On the basis of end user, the precision farming software market is segmented into healthcare providers, research centers & government institutes, pharmaceutical & biotechnology companies, and others. Health provider commanded the largest share of the precision software market in 2018 with the growing availability of precision medicine software and a rising emphasis on providing personalized medicine in hospitals.

You Can Directly Buy This Report From Here::

(Get key industry insights spread across 280 pages with 256 market data tables & 61 figures & charts from the report)

North America Dominates the Market, While Asia Pacific Leads the Growth

North America commanded the largest share of the precision medicine software market in 2018, followed by Europe and Asia Pacific. The major share of this region is mainly attributed to the increase in the geriatric population suffering from chronic diseases such as cancer. In addition, rising government investment and favorable initiatives for the implementation of precision medicine software further support the growth of the North American precision medicine software market. However, Asia-Pacific region is projected to grow at a significant pace in the next few years, mainly due to the growing burden of genetic diseases throughout the region.

Key Players in the Precision Medicine Software Market

The key players operating in the globalprecision medicine software marketareSyapse, Inc. (U.S.), Fabric Genomics, Inc (U.S.), SOPHiA GENETICS SA (France), Human Longevity, Inc. (U.S.), Sunquest Information Systems, Inc. (U.S.), Lifeomic Health, LLC (U.S.), 2bPrecise LLC (U.S.), Foundation Medicine Inc. (U.S.), PierianDx Inc. (U.S.), Gene42 Inc. (Canada), N-of-One Inc. (A Subsidiary of Qiagen N.V.) (U.S.), and Translational Software Inc. (U.S.).

Download Free Sample Copy Of The Report::

Related Reports::

1Healthcare Barcode Technology Market Size by Product (Barcode Printers, Barcode Verifiers, and Barcode Scanners) by application (Clinical and Non-Clinical) Global Forecasts to 2022

2 Artificial Intelligence In Healthcare Market By Product (Hardware, Software, Services), Technology (Machine Learning, Context-Aware Computing, NLP), Application (Drug Discovery, Precision Medicine), End User, And Geography Global Forecast To 2025

3 Clinical Trial Materials and Supplies Market by Service (Logistics, Manufacturing), Clinical Trial Type (Therapeutic, Diagnostics), Phase (Phase 2, Phase 3), Medical Specialty (Oncology, Diabetes), and End User (Pharmaceutical, CRO)- Global Forecast to 2025

About Meticulous Research

The name of our company defines our services, strengths, and values. Since its inception, we have only thrived to research, analyze and present the critical market data with great attention to details. Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

Contact Us:

Meticulous ResearchEmail-sales@meticulousresearch.comContact Sales- +1-646-781-8004Connect with us on LinkedIn-

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Here is the original post:
Precision Medicine Software Market to Register the Highest Growth Rate by Applications, and Future F -

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

What is the evolutionary purpose of menopause? – University of Georgia

The Slow Moon Climbs delves into the science, history and meaning of this life shift

Menopausethat time in every womans life when the ovaries no longer release an egg each month and menstruation ceases foreveris a rare thing among Earths infinitely varied creatures. Humans and a few species of whales are the only mammals that experience menopause, where females live on for many decades in spite of the inability to reproduce. Scientists, psychologists and doctors have been puzzling over that fact for centurieswhat good are older women (or whales) once they lose their fertility? There must be some huge evolutionary benefit that renders womens lives so valuable post-reproduction that they actually live six to eight years longer than men everywhere around the world.

Indeed, the years after a woman experiences menopause can be incredibly productive and influential, according to Susan Mattern, Distinguished Research Professor of History at the University of Georgia and author of The Slow Moon Climbs: The Science, History, & Meaning of Menopause. She opens her book with an extraordinary example: that of Hoelun, the mother of the notorious Genghis Khan. Hoelun accomplished far more than simply giving birth to the notorious emperor of the Mongol Empire. Khan has more than 35 million direct male-line descendants. After Hoelan stopped having children she was critical in keeping her brood safe, leading them in a mission of revenge, and helping to turn the Mongols into a people.

Mattern contends that menopause emerged when we evolved away from chimpanzees millions of years ago. Longevity is what separates humans from chimpanzees and other apes, explained the 53-year-old historian. On average, we live twice as long as chimpanzees. After menopause, women could care for their grandchildren, nieces and nephews. They could forage and grow food, producing more than they consumed. This idea is often called the Grandmother Hypothesis, a concept that emerged in the 1990s, wherein older women are favored by evolution because they enhance human survival.

Yet today, said Mattern, we dont look kindly on menopause, seeing it primarily as a medical malady to be either stoically borne or treated with hormones, antidepressants and other medications. Thats just fundamentally wrong, she contended. People see the word menopause in the title of my book and they assume its a depressing book when in fact its full of good news.

Mattern reports that menopause wasnt even a concept in the ancient Mediterranean cultures she has spent her professional life studying: those of Mesopotamia, Egypt, Israel, Greece and Rome. Ancient physicians and writers didnt write or talk about menopause, she explained. There wasnt a word for it. In fact, one ancient Roman physician, Soranus, thought that menstruation, not menopause, was unhealthy for women and rendered them fragile.

It wasnt until the 18th century that menopause became a mainstream concept. The term itself was coined by a French physician in 1821. It was also referred to as womens hell and the death of sex. Sigmund Freud referred to menopausal women as quarrelsome, vexatious and overbearing. A 1966 best seller,Feminine Forever, called post-menopausal women castrates. By the 1920s the first hormones were synthesized in the laboratory, and by 1938 synthetic estrogen had been developed. Menopause was soon infused with this idea of a deficit of estrogen, said Mattern. It is still a medicalized condition today, although medical nuance has been added with large studies examining the risks and benefits of estrogen alone, or estrogen with progesterone, and even in some cases adding in a dollop of testosterone, all to treat menopause.

Of late, though, attitudes toward menopause have begun to shift. Last year, the popular streaming show Fleabag featured a bar-stool soliloquy on the magnificence and freedom of menopause by famed actress Kristin-Scott Thomas. As the Los Angeles Times noted, It may be the best three minutes of television ever; any woman over 45, or under 45, should have it on a loop. Salon joined in as well with a piece entitled TVs changing view of the change.

Menopause is a legitimate phase of life, said Mattern, and we wouldnt be human without it; its part of what makes us a super adaptable unique species. In agrarian societies, she says, midlife was a time when a woman became a mother-in-law and a grandmother and held more status and power in the family. Weve lost that, while weve gained status in other ways, she explained, through business and the workplace. But weve lost the idea that there is a midlife stage that is valuable in its own right.

Theres a casual ageism in our culture that we need to consciously shift, she believes. Mattern dove into this topic in part because of her own personal experience: her second husband is 20 years younger than she. That made me think about menopause, she said, and my supposed expiration date. Our culture has an antipathy to aging and to midlife, and I wondered, Once I transition through menopause, should I still be sexual? Is it OK to have a younger husband? Will I be ugly or unworthy somehow?

The answer, she found out, is just the opposite. Her marriage has remained good and close through menopause, she is productive, and I feel liberated. Post-reproductive life is useful because we transfer resources, knowledge and energy to younger generations. Thats good news for the more than the 100 million Americans over age 50.

Read the original here:
What is the evolutionary purpose of menopause? - University of Georgia

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

34 Years with a New Heart and Counting | 90.1 FM WABE – WABE 90.1 FM

Whenever Harry Wuest has a doctors appointment in northern Atlantas hospital cluster dubbed Pill Hill, he makes sure to stop by the office of Dr. Douglas Doug Murphy for a quick chat.

And Murphy, unless hes tied up in the operating room, always takes a few minutes to say hello to his former patient. Remember when . . . ? is how the conversation typically starts, and its always tinged with laughter, often joyful, sometimes bittersweet.

Its a reunion of two men who shaped a piece of Georgias medical history.

Almost 35 years ago, Murphy opened the chest of Wuest and sewed in a new heart, giving him a second shot at life. Wuest was the third heart transplant patient at Emory University Hospital.

Tall, lanky, with short curly hair and a quiet demeanor, Wuest is the longest-surviving heart transplant recipient in Georgia and one of the longest-surviving in the world. The 75-year-old accountant still plays golf twice a week and only recently went from working full-time to part-time.

My heart is doing just fine, he says.

Murphy is now the chief of cardiothoracic surgery at Emory Saint Josephs Hospital and still in the operating room almost every day. He has moved on to become the worlds leading expert in robotically assisted heart surgery.


Harry Wuest is originally from Long Island, N.Y. After a stint in the U.S. Air Force, he moved to Florida to work and go to school. He wanted to become a physical education teacher. Then, in 1973, he fell ill. It started with some pain on his left side. He didnt think much of it, but when he got increasingly winded and fatigued, he went to see a doctor.

Several months and numerous specialists later, he received the diagnosis: Cardiomyopathy, a disease of the heart muscle that can make the heart become enlarged, thick and rigid, preventing it from pumping enough blood through the body.

They didnt know how I got it, says Wuest, sitting back in a brown leather armchair in the dark, wood-paneled living room of his Stone Mountain home. Maybe it was a virus. And back then, there wasnt much they could do to treat it, except bed rest.

For the next 12 years, Wuest lived life as best as he could. He got a degree in accounting from the University of Central Florida and worked for a real estate developer. There were good days, but there were more bad days. He was often too weak to do anything, and his heart was getting bigger and bigger.


The first successful human-to-human heart transplant was performed in Cape Town, South Africa, in 1967 a medical breakthrough that catapulted the surgeon, Dr. Christiaan Barnard, onto the cover of Life magazine and to overnight celebrity status.

This highly publicized event was followed by a brief surge in the procedure around the world, but overall, heart transplants had a rocky start. Most patients died shortly after the surgery, mainly due to organ rejection. Back then, immunosuppressive drugs, which can counteract rejection, were still in their infancy. Many hospitals stopped doing heart transplants in the 1970s.

That changed with the discovery of a highly effective immunosuppressive agent. Cyclosporine got FDA approval in 1983 and altered the world of organ transplants.

It was shortly thereafter when Emory University Hospital decided to launch a heart transplant program, but none of the senior surgeons wanted to do it. Even with the new drug, it was a risky surgery, and mortality was still high.

Its an all-or-nothing operation, Murphy says, as he sits down in his small office overlooking the greyish hospital compound. Hes wearing light blue scrubs from an early morning surgery. At 70, he still has boyish looks, with a lean build and an air of laid-back confidence. If you have a number of bad outcomes initially, it can be detrimental to your career as a surgeon, he says.

But Murphy didnt really have a choice. He remembers that during a meeting of Emorys cardiac surgeons in 1984, he was paged to check on a patient. When he returned, the physicians congratulated him on being appointed the head of the new heart transplant program. He was the youngest in the group and had been recruited from Harvards Massachusetts General Hospital just three years before.

Yeah, thats how I became Emorys first transplant surgeon, says Murphy.

He flew to California to shadow his colleagues at Stanford University Hospital, where most heart transplants were performed at the time. Back home at Emory, he put together a team and rigorously rehearsed the operation. The first transplant patient arrived in April 1985. The surgery was successful, as was the second operation less than a month later.

Around the same time, Harry Wuest wound up in a hospital in Orlando. He needed a transplant, but none of the medical centers in Florida offered the procedure. One of his doctors recommended Emory, and Wuest agreed. I knew I was dying. I could feel it. He was flown to Atlanta by air ambulance and spent several weeks in Emorys cardiac care unit until the evening of May 23, when Murphy walked into his room and said, Weve got a heart.


The heart, as the patient later learned, came from a 19-year-old sophomore at Georgia Tech who had been killed in a car crash.

Organ transplants are a meticulously choreographed endeavor, where timing, coordination and logistics are key. While Murphy and his eight-member team were preparing for the surgery, Wuest was getting ready to say farewell to his family his wife and three teenage sons and to thank the staff in the cardiac ward.

I was afraid, he recalls, especially of the anesthesia. It scared the heck out of me. He pauses during the reminiscence, choking briefly. I didnt know if I was going to wake up again.

The surgery took six hours. Transplants usually happen at night because the procurement team, the surgeons who retrieve different organs from the donor, only start working when regularly scheduled patients are out of the operating room.

Despite the cultural mystique surrounding the heart as the seat of life, Murphy says that during a transplant surgery, its not like the big spirit comes down to the operating room. Its very technical. As the team follows a precise routine, emotions are kept outside the door. We dont have time for that. Emotions come later.

After waking up from the anesthesia, Wuests first coherent memory was of Murphy entering the room and saying to a nurse, Lets turn on the TV, so Harry can watch some sports.

Wuest spent the next nine days in the ICU and three more weeks in the hospital ward. In the beginning, he could barely stand up or walk, because he had been bedridden weeks before the surgery and had lost a lot of muscle. But his strength came back quickly. I could finally breathe again, he says. Before the surgery, he felt like he was sucking in air through a tiny straw. I cannot tell you what an amazing feeling that was to suddenly breathe so easily.

Joane Goodroe was the head nurse at Emorys cardiovascular post-op floor back then. When she first met Wuest before the surgery, she recalls him lying in bed and being very, very sick. When she and the other nurses finally saw him stand up and move around, he was a whole different person.

In the early days of Emorys heart transplant program, physicians, nurses and patients were a particularly close-knit group, remembers Goodroe, whos been a nurse for 42 years and now runs a health care consulting firm. There were a lot of firsts for all of us, and we all learned from each other, she said.

Wuest developed friendships with four other early transplant patients at Emory, and he has outlived them all.

When he left the hospital, equipped with a new heart and a fresh hunger for life, Wuest made some radical changes. He decided not to return to Florida but stay in Atlanta. Thats where he felt he got the best care, and where he had found a personal support network. And he got a divorce. Four months after the operation, he went back to working full-time: first in temporary jobs and eventually for a property management company.

After having been sick for 12 years, I was just so excited to be able to work for eight hours a day, he recalls. That was a big, big deal for me.

At 50, he went back to school to get his CPA license. He also found new love.

Martha was a head nurse in the open-heart unit and later ran the cardiac registry at Saint Josephs Hospital. Thats where Wuest received his follow-up care and where they met in 1987. Wuest says for him it was love at first sight, but it took another five years until she finally agreed to go out with him. Six months later, they were married.

Having worked in the transplant office, I saw the good and the bad, Martha Wuest says. A petite woman with short, perfectly groomed silver hair, she sits up very straight on the couch, her small hands folded in her lap.Not every transplant patient did as well as Harry. And I had a lot of fear in the beginning. Now he may well outlive her, she says with a smile and a wink.

Wuests surgeon, meanwhile, went on to fight his own battles. Two and a half years into the program, Murphy was still the only transplant surgeon at Emory and on call to operate whenever a heart became available. Frustrated and exhausted, he quit his position at Emory and signed up with Saint Josephs (which at the time was not part of the Emory system) and started a heart transplant program there.

At St. Joes, Murphy continued transplanting hearts until 2005. In total, he did more than 200 such surgeries.

Being a heart transplant surgeon is a grueling profession, he says, and very much a younger surgeons subspecialty.

He then shifted his focus and became a pioneer in robotically assisted heart surgery.He has done more than 3,000 operations with the robot, mostly mitral valve repairs and replacements more than any other cardiac surgeon in the world.


Since Murphy sewed a new heart into Wuest, 35 years ago, there has been major progress in the field of heart transplants,but it has been uneven.

Medications to suppress the immune system have improved, says Dr. Jeffrey Miller, a transplant surgeon and heart failure specialist at Emory. As a result, we are seeing fewer cases of rejections of the donor heart.

Also, there are new methods of preserving and transporting donor hearts.

Yet patients requiring late-stage heart failure therapy, including transplantation, still exceed the number of donor hearts available. In 2019, 3,551 hearts were transplanted in the United States, according to the national Organ Procurement and Transplantation Network. But 700,000 people suffer from advanced heart failure, says the American Heart Association.

New technologies and continued research are providing hope to many of these patients. There has been significant progress in the development of partial artificial hearts, known as Left Ventricular Assist Devices, or LVADs, says Miller.

These are implantable mechanical pumps that assist the failing heart. Patients are back out in society living normal lives while theyre waiting for their donor hearts, he explains.

LVADs are used not only as bridge devices but as destination therapy as well, maintaining certain patients for the remainder of their lives.

Also, total artificial hearts have come a long way since the first artificial pump was implanted in a patient in 1969.

Long-term research continues into xenotransplantation, which involves transplanting animal cells, tissues and organs into human recipients.

Regenerative stem cell therapy is an experimental concept where stem cell injections stimulate the heart to replace the rigid scar tissue with tissue that resumes contraction, allowing for the damaged heart to heal itself after a heart attack or other cardiac disease.

Certain stem cell therapies have shown toreverse the damage to the heart by 30 to 50 percent, says Dr. Joshua Hare, a heart transplant surgeon and the director of the Interdisciplinary Stem Cell Institute at the University of Miamis Miller School of Medicine.

All of these ideas have potential, says Miller. But they have a lot of work before were ready to use them as alternatives to heart transplantation. I dont think were talking about the next few years.

Besides Emory, other health care systems in Georgia that currently have a heart transplant program are Piedmont Healthcare, Childrens Healthcare of Atlanta and Augusta University Health.

Organ rejection remains a major issue, and long-term survival rates have not improved dramatically over the past 35 years. The 10-year survival is currently around 55 percent of patients, which makes long-term-survivors like Harry Wuest rare in the world of heart transplants.

The United Network of Organ Sharing, or UNOS, which allocates donor hearts in the United States, doesnt have comprehensive data prior to 1987. An informal survey of the 20 highest-volume hospitals for heart transplants in the 1980s found only a scattering of long-term survivors.


Being one of the longest-living heart transplant recipients is something that Wuest sees as a responsibility to other transplant patients, but also to the donors family, which hes never met. If you as a transplant recipient reject that heart, thats like a second loss for that family.

Part of this responsibility is living a full and active life. Both he and Martha have three children from their previous marriages, and combined they have 15 grandchildren. Most of their families live in Florida, so they travel back and forth frequently. Wuest still works as a CPA during tax season, and he does advocacy for the Georgia Transplant Foundation. In addition to golf, he enjoys lifting weights and riding his bike.

Hes had some health scares over the years. In 2013, he was diagnosed with stage 1 kidney cancer, which is in remission. Also, he crossed paths with his former surgeon, and not just socially. In 2014, Murphy replaced a damaged tricuspid valve in Wuests new heart. That operation went well, too.

Murphy says there are several reasons why Wuest has survived so long. Obviously, his new heart was a very good match. But a patient can have the best heart and the best care and the best medicines and still die a few months or years after the transplantation, the surgeon says. Attitude plays a key role.

Wuest was psychologically stable and never suffered from depression or anxiety, Murphy says. Hes a numbers guy. He knew the transplant was his only chance, and he was set to pursue it.

Wuest attributes his longevity to a good strong heart from his donor; good genetics; great doctors and nurses; and a life that he loves. Im just happy to be here, he says.

Quoting his former surgeon and friend, he adds: Doug always said, Having a transplant is like running a marathon. And Im in for the long haul.

Katja Ridderbusch is an Atlanta-based journalist who reports for news organizations in the U.S. and her native Germany. Her stories have appeared in Kaiser Health News, U.S. News & World Report and several NPR affiliates.

This is a slightly modified version of the article 34 Years with a New Heart, published by Georgia Health News on February 18, 2020.

Excerpt from:
34 Years with a New Heart and Counting | 90.1 FM WABE - WABE 90.1 FM

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Seahawks really need to let these five free agents walk – 12th Man Rising

The Seahawks have about ten thousand free agents this offseason. Okay, so the number is actually 32. Ten thousand was only a slight exaggeration, especially when you consider that 22 of those are unrestricted free agents. Thanks to, you can see the list of all 32 right here. The 22 that are free to sign with any team are listed here. Of those 22, the Hawks are definitely going to make some a top priority. Jadeveon Clowney is obviously a player that Seattle will want back, and we have a great look at what it might take to keep him. Right now, Im going to take a look at the five players the Seahawks should be happy to see walk out the door.

I cant keep you in suspense with this choice because everyone expects it. My first choice for a fond farewell package has to be Germain Ifedi. I know, I know, Ive written enough critical pieces on Ifedi, it must seem like he owes me $10 from high school. By all accounts, he is an excellent human being. What he is not is an excellent NFL tackle. Im happy to say that hes turned into a not-terrible player. Pro Football Focus ranked him 64th out of 81 rated players at tackle last year. That was the best performance of his career. That isnt exactly great.

The reason I say the Seahawks absolutely have to let him walk is less about his ability than his price tag. Weve discussed this in-depth previously, but Ifedi is expected to command a salary of at least $12 million per year. Crazy, I know. Thats what happens when there are very few free agents at your position who were at least capable of holding down a starting gig. If by some miracle the market isnt there, and the Hawks could bring him back for something around $7 milafter all, he has improved every year. Not that hell ever sign for that little.

My next big target and I mean big in every sense of the word is Jarran Reed. Hes expected to be offered at least $10 million per year according to Sam Gold of The Athletic:

Reed took offense, as he made clear in his reply, stating Yikes thats disrespectfully low. Gold replied in kind.Reeds response tells me volumes about the guy:

Gotta love how extremely respectful Reed was in his reply to Gold. Which still doesnt mean hes worth more than $10 million. Yes, he created terrific interior pressure on the quarterback in 2018. Projecting his 202 season, before the suspension, I cautioned 12s it was a mistake to expect another double-digit sack total. As I mentioned then, prior to his breakout season he had three sacks in 21 starts. 2019 is the year that really matters. In 10 games, Reed managed just two sacks, eight quarterback hits, and zero tackles for a loss. Prorated to a full season, thats three sacks, 13 QB hits, and still not one tackle for a loss. A reminder: not even Cortez Kennedy ever had more than one double-digit sack season. Id love to have Reed back, but if hes thinking over $12 million per year, theres just no way hes worth that.

Just an aside, but I am not going to suggest the Seahawks part ways with C.J. Prosise. Ive made that call every season since birth, it seems, and he keeps coming back. Last year, he was finally able to make some solid contributions. With the terrible luck hes had with injuries, 33 touches is solid. Theres not much reason to resign him, except that the Hawks love the guy, and he does give his best every time out. So I fully expect to see him re-signed.

Back to the guys who will find new homes. This will be a quick run through. I cant imagine defensive end Ezekiel Ansah will be back at any price. Hes just 30, but has the body of a 90-year old. A 90-year-old with a long history of injuries, that is. I dont wish to offend any longevity-blessed readers. Ziggy just cant get healthy, or stay healthy. I really wish he could.

I think its time for the Hawks to part with Jaron Brown as well. His catch rate (57 percent) was the worst of anyone on the team not named Moore. He lacks the explosion of Moore, and his role as a red-zone target has definitely been superseded by DK Metcalf and the tight end roster. Malik Turner did a fine job as well, so Brown look to be the odd man out.

My last call is all in the players hands. George Fant has made it known that he wants to start at left tackle. That would be a problem, as the Seahawks already have a pretty good player there in Duane Brown. I would love to see big George installed at right tackle in place of Ifedi. I believe the Hawks would like that as well. But if the mans dream is to play on the blind side, hell have to move on. I so badly want to see him stay, catch a pass and not stumble until hes trucked the entire back seven of a defense. Hopefully the Niners.

Visit link:
Seahawks really need to let these five free agents walk - 12th Man Rising

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

County arts council announces ‘Creative Age’ symposium – The Spectrum

Arts and Healing Across the Lifespan serves as the theme of the 4th annual Creative Age symposium organized by the Arts Council of Washington County.

Jeremy Nobel, M.D., founder of the Foundation for Art & Healing (FAH), is Board Certified in both Internal Medicine and Preventative Medicine, with masters degrees in Epidemiology and Health Policy from Harvard School of Public Health, where he serves on the adjunct faculty.(Photo: Arts Council of Washington County)

We have brought together some of the best thinkers in arts therapy for this one-day, intensive symposium, said Paula Bell, chair of the event. So much exciting research shows the proven benefits, regardless of age, of participating in the arts for longevity, mobility, cognitive ability and quality of life for all.

The symposium features two inspiring keynote speakers and 14 breakout sessions, with entertainment from a concert pianist. Bell suggests the symposium is targeted to parents and teachers; psychologists; counselors; doctors; caregivers; arts, music and drama therapists; those working with patients with dementia, Alzheimers and Parkinsons; and those aspiring to understand the loneliness epidemic.

Jeremy Nobel, M.D., founder of the Foundation for Art & Healing (FAH), embodies in a most personal way the effort to enlist art and science in the relief of human suffering. Nobel, who is Board Certified in both Internal Medicine and Preventative Medicine, with masters degrees in Epidemiology and Health Policy from Harvard School of Public Health, where he serves on the adjunct faculty, is also a poet, a photographer, and a teacher a practitioner of the humanities. He is scheduled to attempt to answer the question, Can creative expression be medicine?

Nobel will help participants discover how creative expression reduces the physical and emotional burden associated with various types of health conditions and life circumstances," said Ken Crossley, co-chair of the event.

Nobels Unlonely Project is the signature initiative of FAH, a project whose mission is to broaden public awareness of the negative physical and mental health consequences of loneliness, while promoting creative arts-based interventions to reduce its burden. The project has garnered national visibility, including being featured on the Today Show, The New York Times and Psychology Today. Nobel will present a breakout session, Deep Dive with Jeremy Nobel.

Erica Curtis, certified marriage and family therapist, as well as author, speaker and instructor at UCLArts & Healing, co-authored with Ping Ho, the award-winning book, The Innovative Parent: Raising Connected, Happy, Successful Kids through Art.(Photo: Katie Lubbers)

Erica Curtis, certified marriage and family therapist, as well as author, speaker and instructor at UCLArts & Healing, co-authored with Ping Ho, the award-winning book, The Innovative Parent: Raising Connected, Happy, Successful Kids through Art. As a keynote speaker, Curtis is scheduled to address how art may help parents temper storms of emotion, defuse sibling conflicts, get teeth brushed, and raise happy, successful kids. Her approach has been described as simple, doable and fun.

She believes talking to kids often is not effective, especially when it comes to calming emotions. In her hands-on keynote, Curtis will share art therapy trade secrets to address the countless challenges faced by children and teens when words are inadequate or inaccessible. From anger to anxiety and daily struggles, this session equips the participant with practical tools for calming kids, and is geared toward parents, grandparents, and professionals alike.

Dr. Massimiliano Frani, concert pianist and founder of Genote Health Music, is scheduled to provide entertainment at the Creative Age symposium and will also lead a breakout discussion focused on providing tools to better understand the effects of health music on aging and recovery processes.(Photo: Arts Council of Washington County)

Dr. Massimiliano Frani, concert pianist and founder of Genote Health Music, will provide entertainment on Saturday morning after breakfast and will also lead a breakout discussion focused on providing tools to better understand the effects of health music on aging and recovery processes. Participants may assess health music applications as a non-pharmacological intervention. As master pedagogue, he performs and lectures worldwide about music as medicine and its effects in physical and mental health, education and sports. He has presented Health Music papers, training sessions and conferences worldwide and is the recipient of the Melvin Jones Humanitarian Award.

Other presenters include Vicky Morgan, Victoria Petro-Eschler, Debra Eve, Joni Wilson, Chara Huckins, Dr. Brandt Wadsworth, Barbara Lewis, Nicholas Cendese, Karen Carter, Dr. David Tate, Sharon Daurelle, Emily Christensen, Alex Mack, Saundra Shanti and Rev. Claudia Giacoma.

Bell says the event should havesomething engaging for everyone, including music, dance, art, theater, singing and spiritual care.

This symposium and these workshops are topnotch," Crossley said.

The symposium is slated for Saturday, February 29, 2020, at the Eccles Fine Arts Center on the campus of Dixie State University from 8 a.m. to 5 p.m., with an opening reception in downtown St. George Friday evening from 6 p.m. to 8p.m. at ART Provides Gallery, 35 N.Main Street.

Registration and a light breakfast begin at 7:30 a.m. on Saturday, with lunch at noon, and speakers and workshops continuing until 5p.m. Both meals and symposium materials are included in a registration fee of $50, with seniors and students charged $35. To register for the event, go to and click on the ticket link.

For a list of hotels and lodging opportunities, additional information and questions, please call 435-238-4948 or email

In addition, participants may earn CEU credits in physical therapy, occupational therapy, recreational therapy, social work and arts and music therapy, with up to seven credits available. Applications are available at the registration desk. CEU credits are available for a $15processing fee, which may be prepaid online or with registration at the door.

JJ Abernathy is an arts advocate and musician, and may be contacted at

Read or Share this story:

Read the original:
County arts council announces 'Creative Age' symposium - The Spectrum

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Staying ahead in the UKs race for tech talent – ITProPortal

Its no secret that the UK is undergoing serious change, especially as the Brexit deadline edges ever closer. But while the impact of these changes is being felt across the nation, so far its done little to impede the burgeoning tech industry. Tech Nation recently found that investment for UK scale-up tech firms has been far from stagnant, growing by 61 per cent between 2017 and 2018. In terms of venture capital investment, this makes the UK fourth in the world, behind only the US, China and India and above all other European countries.

Perhaps unsurprisingly, the number of job vacancies within the technology sector has followed suit. Across the industry, there is currently an increasing need both for technical specialists and those in non-technical roles including marketing, human resources and accountancy. For those looking to make a move whether they are dissatisfied in their current position or looking for a change in career direction the volume and variety of vacancies presents an enticing opportunity.

Yet the digital skills gap has also brought about significant challenges for businesses. Its no longer simply a case of filling positions as a company expands, but also ensuring that the best and brightest talent stay within the organisation. Adding to this complexity is the rise of the quitting economy. As the idea of a traditional job for life becomes all but a distant memory, more people are voluntarily leaving their jobs than ever before. This is particularly evident among the younger generation, where 43 per cent of millennials plan to quit their job within two years, according by a recent Deloitte report.

This shift in employee attitudes, coupled with the ongoing war for digital skills, has created a difficult and intricate situation for technology organisations, whereby the number of suitable talent options falls short of the number of positions that need filling.

With the tech industry advancing at an unprecedented rate, its vital that businesses take a proactive approach to both attracting and retaining candidates. This is not only invaluable to the longevity of a business, but also key for gaining an upper hand in the competitive digital talent landscape.

As a first step, businesses in the tech sector must reconsider and reform their mind-set towards HR, shifting their focus towards people and culture. This involves ensuring that key players in the internal hiring process are seen as fulfilling more than an administrative role, and are instead fully involved in the companys decision-making process.

As the role of HR in the technology sector undergoes a transition, it vitally important that business leaders implement methods to really understand their workforce. And this is made possible by moving away from relying solely on traditional methods to applying a holistic approach. Only then can solutions be created which minimise the impact of the skills shortage, reduce churn and negate the low retention rates which are endemic across a number of industries, not just tech.

While its true that the fast-growing UK tech industry has created challenges for organisations, its also given rise to new technologies which can help ease the load, both by automating time-consuming administrative tasks and providing teams with essential insight into their people.

People analytics, for example, allow business leaders to derive an in-depth understanding of their workforce by collecting and analysing employee data. This insight can be used to identify key employees and departmental connections, allowing organisations to achieve a Google Earth view of the workplace. This information can also help anticipate issues early on and prevent them becoming more serious.

Business leaders can also use employee data to get a better picture of the individuals who make up their company. What are their likes or dislikes? Whats their commute like and how does it impact their lives? By having a deep and personalised understanding of each employee, businesses can implement new, more flexible ways of working, as well as strategies to help enhance work-life culture. And, with new data-driven technologies helping to automate administrative tasks, team leaders can strategically focus on the people and, in turn, on growing the business.

As the tech industry continues to fuel the expanding job market, the pressure on businesses to hire the best and brightest talent will only increase. To survive and succeed in this competitive environment, organisations are required to focus on delivering a personalised and positive employee experience. Through adopting a modern, holistic approach, using data to build a detailed and actionable picture of the entire workplace, business leaders can begin to really understand the workforce and their needs.

In doing so, organisations within the technology sector can navigate obstacles such as the digital skills gap and the quitting economy. And by getting ahead in the tech talent race, they can help businesses continue to drive innovation and progress within the UK tech industry.

Ronni Zehavi, CEO, Hibob

The rest is here:
Staying ahead in the UKs race for tech talent - ITProPortal

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Steer clear of the dry fasting diet trend – York Dispatch

A new fad diet includes consuming no water or liquids of any kind for many hours or days at a time, which is dangerous. (Dreamstime/TNS)(Photo: Dreamstime / TNS)

A new fad diet making the rounds on wellness influencer Instagram wont actually help you lose weight. And it could cause dehydration, urinary tract infections, kidney stones, organ failure even death.

Its called dry fasting. It goes beyond what most of us would consider fasting abstaining from solid food or liquid calories and requires consuming no water or liquids of any kind for many hours or even days at a time.

Instagram and other social media sites have provided a glossy new platform for extremely dubious health and nutrition claims. Posts about dry fasting often tout the need to heal or rest or reset your kidneys, or boost their filtration. In practice, what dry fasting will do is make you look a bit more toned, because your body is using up the water in your cells for energy.

Even more dubious claims suggest that dry fasting forces your body to burn toxins, or fat, or inflammation, or tumors. It does not. When you stop feeding your body calories, it breaks down muscle and fat. The toxic byproducts of that breakdown process build up in your system, requiring extra hydration to flush them out.

In other words, if youre abstaining from food, your body needs more water, not less.

Experts agree: There is no dietary or nutritional reason to go on a dry fast.

I dont recommend it at all, said Dr. Pauline Yi, a physician at UCLA Health Beverly Hills who regularly treats patients in their late teens and early 20s. She said intermittent fasting and other fasting-type diets are a popular topic with patients, and she has no problem with people trying them out.

But I also tell them when youre fasting you have to drink water, she said. You cannot go without hydration.

The majority of the human body is water. Your individual water consumption needs depend on your height, weight, health and the climate, but generally speaking, Yi said people should be consuming at least 68 ounces almost nine cups of water every day.

Cary Kreutzer, an associate professor at USCs schools of gerontology and medicine whose area of expertise includes nutrition and diet, says digestive systems arent meant to have extended breaks. She likened making your kidneys go without water to letting your cars engine run out of oil. You can basically burn out some parts of the car that youre going to have to get replaced, she said. You dont want those replacement parts to include your vital organs.

Another unintended consequence of dry fasting: It sets your body in water-conservation mode.

Your body likes homeostasis, said Yi, the physician. If youre going to cut back on water, your body will produce hormones and chemicals to hold onto any water.

So while you might gain a very short-term benefit by looking a tiny bit more toned while youre severely dehydrated (body-builders have been known to dry fast before competitions for that reason), once you consume liquid again, your body rebounds and desperately hangs on to even more water than before. Its like yo-yo dieting in fast motion.

Dry fasting is not the same thing as intermittent fasting, which has become a popular fad diet in recent years. There are different variations of intermittent fasting, but most people start with 16 hours of fasting followed by eight hours of eating. Martin Berkhan created the LeanGains 16:8 intermittent fasting guide and is widely credited with popularizing the diet. On his website,, Berkhan writes that during the 16-hour fasting window, coffee, calorie-free sweeteners, diet soda, sugar-free gum and up to a teaspoon of milk in a cup of coffee wont break the fast.

The subreddit for fasting, r/fasting, has an Introduction to Intermittent Fasting guide that contains the following tips for surviving the fasting portion of your day:

Drink lots of cold water

Always carry water, a canteen, a bottle, or keep a full glass within sight

Water, water, water, water

Valter Longo has studied starvation, fasting and calorie restriction in humans for nearly 30 years. Hes currently the director of the Longevity Institute at USC and a professor of gerontology. He developed the Fasting-Mimicking Diet, or FMD, a fasting-type diet with small prepackaged meals intended to provide the health and longevity benefits of a five-day fast without requiring a doctors supervision. Fasting-type diets have grown in popularity in recent years for a simple reason, he said: Because they work.

But he said hes not aware of any reputable studies about the effects of dry fasting, and said he wouldnt even consider putting one together, also for a simple reason: Its incredibly dangerous.

For sure, the body needs to reset, but there are safe ways of doing that, and dry fasting is not one of them, Longo said. We require water.

His work has also involved looking at how cultures and religions have engaged with starvation and fasting throughout human history, and says he hasnt heard of any that involved extended fasting without water. The closest is Ramadan, during which observers go without food or water during daylight hours but at most, that lasts for 16 hours, and its preceded and followed by extensive hydration.

If someone tries dry fasting for a full day, Longo said, they risk side effects like developing kidney stones. Longer than that, and you start risking your life.

Some proponents of dry fasting eschew water but recommend hydrating with fresh fruits and vegetables. Hydrating with fruit is certainly better than not hydrating at all. An orange has about a half-cup of water in it; to get to the recommended 68 ounces of water a day, youd have to eat around 17 oranges. Thats a lot of peeling.

So, in conclusion: Dry fasting puts you at risk of kidney stones or organ failure. There are no known, proven long-term benefits to doing it. Though different types of fasts and fasting diets can be beneficial, there is no medical evidence to suggest you need to stop consuming water for any period of time, or that water from fruit is better for you than filtered drinking water. Do not take medical advice from a photo of a person in a sarong.

Please drink some water.

Read or Share this story:

Read more from the original source:
Steer clear of the dry fasting diet trend - York Dispatch

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Page 5«..4567..1020..»